English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
David Beasley
| Jun 26, 2020
Emergency room visits for strokes, heart attacks declined after COVID-19 crisis, study finds
Press release submission
| Jun 21, 2020
REISTONE: Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata
Press release submission
| Jun 14, 2020
CANO HEALTH: Advises Patients Of Potential Data Security Issue
Bob Pepalis
| Jun 3, 2020
Flawed data puts COVID-19 policies, treatments in doubt
Karen Kidd
| Jun 1, 2020
Pandemic expands health care divide between red, blue states, LA Times reports
Press release submission
| May 24, 2020
SYNDAX PHARMACEUTICALS: ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer
Press release submission
| May 15, 2020
AMERICAN UROLOGICAL ASSOCIATION: Studies Highlight Barriers to and Disparities in Access to Care for Patients with Prostate Disease
Bob Pepalis
| Apr 28, 2020
Political science professor calls Mexico's president 'reckless gambler' with COVID-19
Trending
+
Pharmaceuticals
Patient Daily
| Oct 23, 2025
Empower seeks dismissal of Eli Lilly suit in Texas federal court
Patient Daily
| Oct 23, 2025
Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
+
Pharmaceuticals
Patient Daily
| Oct 29, 2025
Paragon Health Institute senior fellow: 340B program 'needs real reform'
Patient Daily
| Oct 23, 2025
Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
« First
«
…
11
12
13
14
15
16
17
…
»
Last »